Evidence map›Paper›PMID 20679229›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment.

Kiran Nistala, Stuart Adams, Helen Cambrook, Simona Ursu, Biagio Olivito, Wilco de Jager, Jamie G Evans, Rolando Cimaz, Mona Bajaj-Elliott, Lucy R Wedderburn

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 233 papers.

0numbers the graph read from it
0cells of the map it votes in
233citing papers in PubMed
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

233 citing papers in PubMed, 437 citations in OpenAlex.

  1. Trial
  2. Article
  3. HLA-DRRespiratory research · 2026
    Article
  4. Article
  5. Article
  6. Transcriptional landscape of CD4+ T cells in Systemic Sclerosis.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Th17 cell pathogenicity in autoimmune disease.Experimental & molecular medicine · 2025
    Review
  13. Article
  14. Augmenting antitumor efficacy of Th17-derived Th1 cells through IFN-γ-induced type I interferon response network via IRF7.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Revisiting T Cells in Chronic Rhinosinusitis.Allergy, asthma & immunology research · 2024
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. NRF2 is a spatiotemporal metabolic hub essential for the polyfunctionality of Th2 cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article

173 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Kiran NistalaRheumatology Unit, University College London Institute of Child Health, London WC1N 1EH, United Kingdom. K.Nistala@ich.ucl.ac.uk
Stuart Adams
Helen Cambrook
Simona Ursu
Biagio Olivito
Wilco de Jager
Jamie G Evans
Rolando Cimaz
Mona Bajaj-Elliott
Lucy R Wedderburn
University College London · GBGreat Ormond Street Hospital · GBMeyer Children's Hospital · ITUniversity Medical Center Utrecht · NLUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In several murine models of autoimmune arthritis, Th17 cells are the dominant initiators of inflammation. In human arthritis the majority of IL-17-secreting cells within the joint express a cytokine phenotype intermediate between Th17 and Th1. Here we show that Th17/1 cells from the joints of children with inflammatory arthritis express high levels of both Th17 and Th1 lineage-specific transcription factors, RORC2 and T-bet. Modeling the generation of Th17/1 in vitro, we show that Th17 cells "convert" to Th17/1 under conditions that mimic the disease site, namely low TGFbeta and high IL-12 levels, whereas Th1 cells cannot convert to Th17. Th17/1 cells from the inflamed joint share T-cell receptor (TCR) clonality with Th17 cells, suggesting a shared clonal origin between Th17 and Th17/1 cells in arthritis. Using CD161, a lectin-like receptor that is a marker of human Th17, we show synovial Th17 and Th17/1 cells, and unexpectedly, a large proportion of Th1 cells express CD161. We provide evidence to support a Th17 origin for Th1 cells expressing CD161. In vitro, Th17 cells that convert to a Th1 phenotype maintain CD161 expression. In the joint CD161+ Th1 cells share features with Th17 cells, with shared TCR clonality, expression of RORC2 and CCR6 and response to IL-23, although they are IL-17 negative. We propose that the Th17 phenotype may be unstable and that Th17 cells may convert to Th17/1 and Th1 cells in human arthritis. Therefore therapies targeting the induction of Th17 cells could also attenuate Th17/1 and Th1 effector populations within the inflamed joint.

Indexed as

Amino Acid SequenceArthritis, JuvenileBase SequenceCell LineageChildFlow CytometryGene ExpressionHumansInterferon-gammaInterleukin-12Interleukin-17Molecular Sequence DataNK Cell Lectin-Like Receptor Subfamily BNuclear Receptor Subfamily 1, Group F, Member 3Receptors, CCR6Reverse Transcriptase Polymerase Chain ReactionCCR6 protein, humanInterferon-gammaInterleukin-12Interleukin-17KLRB1 protein, humanNK Cell Lectin-Like Receptor Subfamily BNuclear Receptor Subfamily 1, Group F, Member 3Receptors, CCR6RORC protein, humanT-bet Transcription FactorT-Box Domain ProteinsTransforming Growth Factor beta

Identifiers

PMID20679229
PMCPMC2930428
OpenAlexW2118794770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.